Frontier IP Group Plc (“Frontier IP”) unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. It is dedicated to supporting start-up companies by taking an active involvement in their growth, including support for fund raising and collaboration with relevant industry partners at an early stage of development. The company was admitted to the AIM Market in 2011, more information can be found at

Frontier IP acts as co-founder with the IP creator and aims to generate value for its shareholders through:

Frontier IP brings an experienced ‘hands-on’ management team and a focus on delivery. Frontier IP holds equity in a portfolio of growing businesses centred around core competences in materials science, active ingredient processing and delivery, medical technology, electronics and automation:

Core Portfolio Company Company business
Alusid Building materials manufactured from recycled industrial waste
Cambridge Raman Imaging Graphene-based high speed lasers
CamgraPhIC Opto-electronics for 5G
Cambridge Simulation Software to model discontinuous processes
Ex Scientia AI-based drug discovery
Fieldwork Robotics Robots for harvesting agricultural products
Molendotech Water testing
Nandi Proteins to reduce sugar, fat and additives in food
NTPE Printable electronics
PoreXpert Porous materials analysis
PulsiV Energy efficient micro-inverters
Tarsis Technology Active ingredient delivery for agricultural applications
The Vaccine Group Zoonotic Barrier Vaccines to address emerging infectious diseases

Frontier IP is a commercialisation partner for a number of universities in the UK and Portugal with plans for further expansion, both in the UK and overseas.